Exact Mass: 504.31723600000004

Exact Mass Matches: 504.31723600000004

Found 91 metabolites which its exact mass value is equals to given mass value 504.31723600000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Eudesobovatol B

[2R-(2alpha,4aalpha,8beta,8abeta)]-Decahydro-8-[2-hydroxy-4-(2-propenyl)-6-[4-(2-propenyl)phenoxy]phenoxy]-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol

C33H44O4 (504.3239424)


   

dipyridamole

dipyridamole

C24H40N8O4 (504.31723600000004)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Dipyridamole

2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)-[1,3]diazino[5,4-d]pyrimidin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol

C24H40N8O4 (504.31723600000004)


Dipyridamole is only found in individuals that have used or taken this drug. It is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)Dipyridamole likely inhibits both adenosine deaminase and phosphodiesterase, preventing the degradation of cAMP, an inhibitor of platelet function. This elevation in cAMP blocks the release of arachidonic acid from membrane phospholipids and reduces thromboxane A2 activity. Dipyridamole also directly stimulates the release of prostacyclin, which induces adenylate cyclase activity, thereby raising the intraplatelet concentration of cAMP and further inhibiting platelet aggregation. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Desglucocoroloside

4-{5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C29H44O7 (504.3086874)


From Corchorus olitorius (Jews mallow). Desglucocoroloside is found in tea, herbs and spices, and green vegetables. Desglucocoroloside is found in green vegetables. Desglucocoroloside is from Corchorus olitorius (Jews mallow). D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   
   
   
   
   
   

acide atroxigenique

acide atroxigenique

C29H44O7 (504.3086874)


   

3beta,7beta,15alpha-trihydroxy-11,23-dioxo-5alpha-lanosta-8-en-26-oic acid|ganoderic acid C

3beta,7beta,15alpha-trihydroxy-11,23-dioxo-5alpha-lanosta-8-en-26-oic acid|ganoderic acid C

C29H44O7 (504.3086874)


   

(3S,5S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-6-ene-3,5,22,25-tetrol 22-acetate|suberoretisteroid E

(3S,5S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-6-ene-3,5,22,25-tetrol 22-acetate|suberoretisteroid E

C29H44O7 (504.3086874)


   

acide lactone atroxigenique

acide lactone atroxigenique

C29H44O7 (504.3086874)


   

(+)-(S)-9-[(Z)-3-(4-methoxyphenyl)prop-2-enoyl]-2-phenyl-1,5,9,14-tetraazabicyclo[12.3.1]octadecan-4-one|(+)-(S)-isoverbamekrine|(2S)-9-[(Z)-3-(4-methoxyphenyl)prop-2-enoyl]-2-phenyl-1,5,9,14-tetraazabicyclo[12.3.1]octadecan-4-one|(S)-isoverbamekrine

(+)-(S)-9-[(Z)-3-(4-methoxyphenyl)prop-2-enoyl]-2-phenyl-1,5,9,14-tetraazabicyclo[12.3.1]octadecan-4-one|(+)-(S)-isoverbamekrine|(2S)-9-[(Z)-3-(4-methoxyphenyl)prop-2-enoyl]-2-phenyl-1,5,9,14-tetraazabicyclo[12.3.1]octadecan-4-one|(S)-isoverbamekrine

C30H40N4O3 (504.310025)


   

6-O-acetyl-3beta-pregna-5,20-dienyl-alpha-L-galactopyranoside

6-O-acetyl-3beta-pregna-5,20-dienyl-alpha-L-galactopyranoside

C29H44O7 (504.3086874)


   

ent-2beta-(2-methyl)butoxy-3,4-dihydro-4alpha-isozuelanin

ent-2beta-(2-methyl)butoxy-3,4-dihydro-4alpha-isozuelanin

C29H44O7 (504.3086874)


   

3-O-acetyl-14alpha-hydroxypinnasterol

3-O-acetyl-14alpha-hydroxypinnasterol

C29H44O7 (504.3086874)


   

spongianolide E|spongianolide F

spongianolide E|spongianolide F

C29H44O7 (504.3086874)


   

2-(3-Methyl-2-butenoyl)----2,3,16,17-Phyllocladanetetrol

2-(3-Methyl-2-butenoyl)----2,3,16,17-Phyllocladanetetrol

C29H44O7 (504.3086874)


   
   

(3S,7S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-5-ene-3,7,22,25-tetrol 22-acetate|suberoretisteroid D

(3S,7S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-5-ene-3,7,22,25-tetrol 22-acetate|suberoretisteroid D

C29H44O7 (504.3086874)


   
   

caseabalansin D|rel-(2S,5R,6R,8S,9S,10R,18R,19R)-19-acetoxy-18-ethoxy-18,19-epoxy-2-(2xi-methylbutanoyloxy)cleroda-3,13(16),14-trien-6-ol

caseabalansin D|rel-(2S,5R,6R,8S,9S,10R,18R,19R)-19-acetoxy-18-ethoxy-18,19-epoxy-2-(2xi-methylbutanoyloxy)cleroda-3,13(16),14-trien-6-ol

C29H44O7 (504.3086874)


   

3beta-(2?-O-acetyl-alpha-L-fucopyranosyloxy)-5alpha-pregna-20-en-19-al|sclerosteroid N

3beta-(2?-O-acetyl-alpha-L-fucopyranosyloxy)-5alpha-pregna-20-en-19-al|sclerosteroid N

C29H44O7 (504.3086874)


   
   

Ganoderic Acid C2

Ganoderic Acid C2

C29H44O7 (504.3086874)


   

1beta,3beta,5alpha,23,24-pentahydroxy-30-norolean-12,20(29)-dien-28-oic-acid

1beta,3beta,5alpha,23,24-pentahydroxy-30-norolean-12,20(29)-dien-28-oic-acid

C29H44O7 (504.3086874)


   

11beta,12beta-epoxy-3alpha,9beta,13alpha-tripropionoxy-1beta,8beta-trinervit-15(17)-ene

11beta,12beta-epoxy-3alpha,9beta,13alpha-tripropionoxy-1beta,8beta-trinervit-15(17)-ene

C29H44O7 (504.3086874)


   

caseargrewiin J|rel-(2R,5S,6S,8R,9R,10S,18S,19S)-18-methoxy-19-acetoxy-18,19-epoxy-2-hexanoyloxy-6-hydroxycleroda-3,12(Z),14-triene

caseargrewiin J|rel-(2R,5S,6S,8R,9R,10S,18S,19S)-18-methoxy-19-acetoxy-18,19-epoxy-2-hexanoyloxy-6-hydroxycleroda-3,12(Z),14-triene

C29H44O7 (504.3086874)


   

(20R,22R,24S,25R)-4beta,20beta-dihydroxy-5beta,6beta-epoxy-3beta-methoxy-1-oxowithanolide

(20R,22R,24S,25R)-4beta,20beta-dihydroxy-5beta,6beta-epoxy-3beta-methoxy-1-oxowithanolide

C29H44O7 (504.3086874)


   
   
   

Lys Lys Met Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanoic acid

C22H44N6O5S (504.3093734)


   

Lys Lys Val Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid

C22H44N6O5S (504.3093734)


   

Lys Met Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-methylbutanoic acid

C22H44N6O5S (504.3093734)


   

Lys Met Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Lys Val Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C22H44N6O5S (504.3093734)


   

Lys Val Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Met Lys Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]hexanamido]-3-methylbutanoic acid

C22H44N6O5S (504.3093734)


   

Met Lys Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-methylbutanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Met Val Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylbutanamido]hexanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Digitoxigenin monodigitoxoside

Digitoxigenin monodigitoxoside

C29H44O7 (504.3086874)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

Val Lys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C22H44N6O5S (504.3093734)


   

Val Lys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Val Met Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanamido]hexanamido]hexanoic acid

C22H44N6O5S (504.3093734)


   

Deglucocoroloside

4-{5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-11-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}-2,5-dihydrofuran-2-one

C29H44O7 (504.3086874)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

ST 29:4;O7

(3S,5S,16S,20R,22R,24S)-16,24:20,24-diepoxycholest-6-ene-3,5,22,25-tetrol 22-acetate

C29H44O7 (504.3086874)


   

1,6,20,25-Tetraaza[6.1.6.1]paracyclophane

1,6,20,25-Tetraaza[6.1.6.1]paracyclophane

C34H40N4 (504.32528)


   

(3alpha,5beta,12alpha)-3,12-bis(acetyloxy)-7-oxocholan-24-oic acid methyl ester

(3alpha,5beta,12alpha)-3,12-bis(acetyloxy)-7-oxocholan-24-oic acid methyl ester

C29H44O7 (504.3086874)


   

BIS(4-N,N-DIETHYLAMINOPHENYL)-(4-N-ETHYLAMINONAPHTHALEN-1-YL)ACETONITRILE

BIS(4-N,N-DIETHYLAMINOPHENYL)-(4-N-ETHYLAMINONAPHTHALEN-1-YL)ACETONITRILE

C34H40N4 (504.32528)


   

PENTAERYTHRITOL PROPOXYLATE

PENTAERYTHRITOL PROPOXYLATE

C22H48O12 (504.3145608)


   

ZL-Asp(tBu)-OH * DCHA

ZL-Asp(tBu)-OH * DCHA

C28H44N2O6 (504.3199204)


   

(1S,2R,3S,4R)-2-((E)-5-(benzyloxy)pent-2-enyl)-3-((tert-butyldimethylsilyloxy)methyl)-4-(tetrahydro-2H-pyran-2-yloxy)cyclopentanol

(1S,2R,3S,4R)-2-((E)-5-(benzyloxy)pent-2-enyl)-3-((tert-butyldimethylsilyloxy)methyl)-4-(tetrahydro-2H-pyran-2-yloxy)cyclopentanol

C29H48O5Si (504.32708379999997)


   

(2R,3S)-8-(3-cyclohexylprop-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-(3-cyclohexylprop-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C30H40N4O3 (504.310025)


   

Desglucocoroloside

Desglucocoroloside

C29H44O7 (504.3086874)


D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides

   

FAHFA 10:3/O-23:7

FAHFA 10:3/O-23:7

C33H44O4 (504.3239424)


   

FAHFA 11:3/O-22:7

FAHFA 11:3/O-22:7

C33H44O4 (504.3239424)


   

FAHFA 12:3/O-21:7

FAHFA 12:3/O-21:7

C33H44O4 (504.3239424)


   

FAHFA 12:4/O-21:6

FAHFA 12:4/O-21:6

C33H44O4 (504.3239424)


   

FAHFA 13:4/O-20:6

FAHFA 13:4/O-20:6

C33H44O4 (504.3239424)


   

FAHFA 14:4/O-19:6

FAHFA 14:4/O-19:6

C33H44O4 (504.3239424)


   

FAHFA 15:4/O-18:6

FAHFA 15:4/O-18:6

C33H44O4 (504.3239424)


   

FAHFA 15:5/O-18:5

FAHFA 15:5/O-18:5

C33H44O4 (504.3239424)


   

FAHFA 16:5/O-17:5

FAHFA 16:5/O-17:5

C33H44O4 (504.3239424)


   

FAHFA 17:5/O-16:5

FAHFA 17:5/O-16:5

C33H44O4 (504.3239424)


   

FAHFA 18:5/O-15:5

FAHFA 18:5/O-15:5

C33H44O4 (504.3239424)


   

FAHFA 18:6/O-15:4

FAHFA 18:6/O-15:4

C33H44O4 (504.3239424)


   

FAHFA 19:6/O-14:4

FAHFA 19:6/O-14:4

C33H44O4 (504.3239424)


   

FAHFA 20:6/O-13:4

FAHFA 20:6/O-13:4

C33H44O4 (504.3239424)


   

FAHFA 21:6/O-12:4

FAHFA 21:6/O-12:4

C33H44O4 (504.3239424)


   

FAHFA 21:7/O-12:3

FAHFA 21:7/O-12:3

C33H44O4 (504.3239424)


   

FAHFA 22:7/O-11:3

FAHFA 22:7/O-11:3

C33H44O4 (504.3239424)


   

FAHFA 23:7/O-10:3

FAHFA 23:7/O-10:3

C33H44O4 (504.3239424)


   
   
   
   
   

4-(3-{3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-3-hydroxybutyl)-3,5-dimethyloxolan-2-one

4-(3-{3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-3-hydroxybutyl)-3,5-dimethyloxolan-2-one

C29H44O7 (504.3086874)


   

1,3-bis(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-decahydronaphtho[4,4a-c]furan-5-yl 2-methylbutanoate

1,3-bis(acetyloxy)-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-decahydronaphtho[4,4a-c]furan-5-yl 2-methylbutanoate

C29H44O7 (504.3086874)


   

{2-hydroxy-1-[2-(2-hydroxy-5-oxo-2h-furan-3-yl)ethenyl]-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl}methyl 3-hydroxybutanoate

{2-hydroxy-1-[2-(2-hydroxy-5-oxo-2h-furan-3-yl)ethenyl]-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl}methyl 3-hydroxybutanoate

C29H44O7 (504.3086874)


   

(1s,3s,5r,6as,7r,8r,10s,10as)-1-(acetyloxy)-10-hydroxy-3-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl hexanoate

(1s,3s,5r,6as,7r,8r,10s,10as)-1-(acetyloxy)-10-hydroxy-3-methoxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl hexanoate

C29H44O7 (504.3086874)


   

4-hydroxy-6-[(7e,9e,11e)-14-hydroxy-9,13,15-trimethyl-17-phenylheptadeca-1,7,9,11-tetraen-1-yl]-3,5-dimethylpyran-2-one

4-hydroxy-6-[(7e,9e,11e)-14-hydroxy-9,13,15-trimethyl-17-phenylheptadeca-1,7,9,11-tetraen-1-yl]-3,5-dimethylpyran-2-one

C33H44O4 (504.3239424)


   

(2r,6r)-6-[(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-6,6,9a,11a-tetramethyl-10-oxo-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

(2r,6r)-6-[(1r,3s,3ar,4s,5ar,7s,9as,11ar)-3,4,7-trihydroxy-6,6,9a,11a-tetramethyl-10-oxo-1h,2h,3h,3ah,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

C29H44O7 (504.3086874)


   

(4as,6as,6br,8as,10s,12r,12as,12bs,14bs)-8a,10,12-trihydroxy-9,9-bis(hydroxymethyl)-6a,6b,12a-trimethyl-2-methylidene-3,4,5,6,7,8,10,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

(4as,6as,6br,8as,10s,12r,12as,12bs,14bs)-8a,10,12-trihydroxy-9,9-bis(hydroxymethyl)-6a,6b,12a-trimethyl-2-methylidene-3,4,5,6,7,8,10,11,12,12b,13,14b-dodecahydro-1h-picene-4a-carboxylic acid

C29H44O7 (504.3086874)


   

[(2r,3r,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-ethenyl-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

[(2r,3r,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-ethenyl-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C29H44O7 (504.3086874)


   

(1s,3r,5r,6as,7s,8s,9s,10as)-1-(acetyloxy)-9-butoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

(1s,3r,5r,6as,7s,8s,9s,10as)-1-(acetyloxy)-9-butoxy-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C29H44O7 (504.3086874)